A global perspective on newborn congenital hypothyroidism screening

Area of Science:

• Endocrinology
• Neonatology
• Genetics

Background:

• Congenital hypothyroidism (CH) is a critical condition in newborns due to thyroid hormone deficiency.
• Untreated CH leads to severe, permanent neurological deficits and metabolic complications.
• Early diagnosis and treatment are vital for preventing long-term health issues in affected infants.

Purpose of the Study:

• To highlight the importance of newborn screening for congenital hypothyroidism.
• To address the ongoing questions regarding the etiology and increasing incidence of CH.
• To emphasize the need for further research into CH detection and treatment, particularly in vulnerable newborn populations.

Main Methods:

• Review of existing literature and screening program data.
• Analysis of trends in CH incidence.
• Identification of knowledge gaps in CH etiology and management.

Main Results:

• Newborn screening has significantly improved CH diagnosis and treatment outcomes.
• The etiology and rising incidence of CH in diverse populations require further investigation.
• Increased CH cases in preterm, low-birth-weight, and NICU infants necessitate enhanced research efforts.

Conclusions:

• Widespread newborn screening is crucial for managing congenital hypothyroidism.
• Further research is essential to understand the causes and increasing prevalence of CH.
• Optimized detection and treatment strategies are needed for all forms of CH, especially in high-risk neonates.